Allan Richard, Scherrer Ramona, Kasap Ozge Erisoz, Paris Laura, Scott Thomas, Sauskojus Hendrik, Wetherill Olivia, Estecha-Querol Sara, Alkhalaf Zaid, Karakus Mehmet, Yilmaz Ayda, Alten Bülent, Messenger Louisa A
The MENTOR Initiative, Haywards Heath, UK.
Department of Biology, Faculty of Science, VERG Laboratories, Hacettepe University, Ankara, Turkey.
BMC Med. 2025 Jul 3;23(1):401. doi: 10.1186/s12916-025-04244-2.
In Syria, during the 14 years after the outbreak of civil war, 16.7 million people have been forced to flee their homes, of which 7.2 million remain internally displaced in 2025. Breakdown in waste management caused by aerial bombardment has created ideal conditions for cutaneous leishmaniasis (CL) transmission, vectored by phlebotomine sandflies. Displaced populations reside in flimsy shelters where conventional vector control tools are operationally unfeasible. A small, lightweight, portable transfluthrin-based spatial repellent (Mosquito Shield™) has been developed which may circumvent some of these logistical issues and provide improved protection from vector-borne diseases in harsh environments.
A two-arm, non-randomised cluster trial was undertaken in Ar-Raqqa governorate, North-East Syria, to evaluate the efficacy of Mosquito Shield™ in reducing CL case incidence and sandfly densities in shelters. Weekly epidemiological monitoring was performed by MENTOR Initiative mobile clinics and supported health facilities. Entomological monitoring was performed fortnightly using indoor US Centers for Disease Control and Prevention light traps in 40 randomly selected households per study arm. Phlebotomine sandflies were morphologically identified; a subset were analysed for molecular species confirmation, blood-meal preferences and pyrethroid resistance. Household surveys and focus group discussions were used to assess intervention feasibility, acceptability and uptake.
Assuming a 2-month diagnosis cut-off, the CL incidence rate was 9.9 and 5.2 per 1000 in the control and intervention arms, respectively; Mosquito Shield™ demonstrated a significant impact on rate of CL infection in all ages (incidence rate ratio; IRR: 0.52 [95% CI: 0.37-0.74]; p < 0.0001). Mosquito Shield™ demonstrated a significant impact on all female sandfly density (IRR: 0.22 [95% CI: 0.14-0.33]; p < 0.0001) and blood-fed female sandfly density (IRR: 0.21 [95% CI: 0.11-0.40]; p < 0.0001). Mosquito Shield™ was received positively and perceived to be easy to use, to protect from CL, sandflies and other insect bites and required minimal behaviour change.
Trial findings provide the first demonstrable impact of spatial repellents on CL transmission, strengthening the growing evidence basis for the effectiveness of this intervention against multiple vector species and their associated pathogens. Study results strongly support the deployment of spatial repellents to control CL in humanitarian crises.
ClinicalTrials.gov, NCT06917040.
在叙利亚,内战爆发后的14年里,1670万人被迫逃离家园,其中720万人在2025年仍处于境内流离失所状态。空袭导致的废物管理崩溃为皮肤利什曼病(CL)的传播创造了理想条件,其传播媒介为白蛉。流离失所者居住在简陋的避难所中,传统的病媒控制工具在这些地方无法实际操作。一种基于四氟甲醚菊酯的小型、轻便、便携式空间驱避剂(Mosquito Shield™)已被研发出来,它可能会规避一些后勤问题,并在恶劣环境中提供更好的保护,预防病媒传播疾病。
在叙利亚东北部的拉卡省进行了一项双臂、非随机整群试验,以评估Mosquito Shield™在降低避难所中CL发病率和白蛉密度方面的效果。MENTOR倡议移动诊所和支持的医疗机构每周进行一次流行病学监测。每个研究组每两周使用美国疾病控制与预防中心的室内诱蚊灯在40个随机选择的家庭中进行昆虫学监测。对白蛉进行形态学鉴定;对一部分白蛉进行分子物种确认、血餐偏好和拟除虫菊酯抗性分析。通过家庭调查和焦点小组讨论来评估干预措施的可行性、可接受性和采用情况。
假设诊断截止时间为2个月,对照组和干预组的CL发病率分别为每1000人9.9例和5.2例;Mosquito Shield™对各年龄段的CL感染率有显著影响(发病率比;IRR:0.52 [95% CI:0.37 - 0.74];p < 0.0001)。Mosquito Shield™对所有雌性白蛉密度有显著影响(IRR:0.22 [95% CI:0.14 - 0.33];p < 0.0001)以及对吸食血液的雌性白蛉密度有显著影响(IRR:0.21 [95% CI:0.